Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PHAR 358 > Parkinson's Disease > Flashcards

Parkinson's Disease Flashcards

1
Q

Parkinson’s Disease is _______, ___________, and ___________________

A

chronic, progressive, neurodegenerative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the pathophysiology of PD?

A

Progressive death of dopamine-producing neurons in the substantia nigra (part of the basal ganglia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why is dopamine important in terms of movement? (3)

A
  • Important for smooth, coordinated, controlled movements
  • Death of dopaminergic neurons -> messages telling the body how and when to move are delivered slowly or incompletely
  • Individual is unable to initiate and control movements in a normal way
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 2 components that make up the substantia nigra? What does each component produce?

A
  1. Pars compacta - dopamine producing
  2. Pars reticulata - GABA neurons
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are 3 risk factors for PD?

A
  1. Family history -> genetic component
  2. Pesticide exposure (rural, farmer, drink well water)
  3. Repeated head injuries
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are 3 protective factors against PD?

A
  1. Cigarette smoking
  2. High coffee consumption
  3. Intensive exercise
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

For the hallmark movement symptoms of PD, remember TRAP. What is that?

A

Tremor
Rigidity
Akinesia/Bradykinesia
Postural instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The key motor features of PD can be remembered as the 3S’s. What are they?

A

Slow
Stiff
Shaky

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the Movement Disorder Society Clinical Diagnostic Criteria for PD?
(What must be present? Need at least 1 of what? What are the supportive criteria?)

A
  1. Must be present - bradykinesia
  2. At least 1 of - rest tremor or rigidity
  3. Supportive criteria:
    - Clear response to dopaminergic treatment
    - Levodopa-induced dyskinesias
    - Olfactory loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are 2 subtypes of PD?

A
  1. Tremor-predominant subtype
    - Often younger PD patients
    - Typically have a slower, more benign course of progression
  2. Akinetic/rigid subtype
    - Often have a more rapid rate of progression of motor symptoms
    - Particularly in older patients – more likely to develop dementia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some medications classes that cause secondary Parkinsonism? (4)

A
  1. Typical APs
  2. Atypical APs
  3. Antinauseants/prokinetics
  4. Miscellaneous
    - Lithium
    - DVP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are 3 typical APs that can cause secondary Parkinsonism?

A
  1. Chlorpromazine
  2. Haloperidol
  3. Prochlorperazine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are 4 atypical APs that can cause secondary Parkinsonism?

A
  1. Risperidone
  2. Olanzapine
  3. Aripiprazole
  4. Ziprasidone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are 3 alternative atypical APs that are less likely to cause secondary Parkinsonism?

A
  1. Quetiapine
  2. Clozapine
  3. Pimavanserin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What antinauseant/prokinetic agent can cause secondary Parkinsonism? What is a safer alternative?

A
  1. Metoclopramide
    Safer alternative = domperidone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the non-motor symptoms of PD that often precede motor symptoms? (5)

A

Hyposmia – loss of sense of smell
Constipation
Depression
Fatigue
REM Sleep Behaviour Disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the non-motor symptoms of PD that are seen early in the disease course? (4)

A

“Flat affect”
Micrographia
Hypophonia – soft speech
Dry eyes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are some of the later non-motor PD symptoms? (5)

A
  1. Psychiatric disturbances – delusions and hallucinations
  2. Sialorrhea (drooling)
  3. Sexual dysfunction
  4. Autonomic dysfunction
    - Orthostatic hypotension
    - Urinary and fecal incontinence
  5. Cognitive impairment and dementia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

True or False? PD treatment modifies disease progression

A

False - no PD treatment modifies disease progression - symptomatic treatment only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the goals of therapy for PD? (4)

A
  1. Reduce signs and symptoms of PD (both motor and non-motor)
  2. Minimize complications of drug therapy
  3. Maintain independence
  4. Improve/maintain quality of life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the non-pharm treatment options for PD? (6)

A
  1. Physical Therapy: Help maintain motor function
  2. Occupational Therapy: Adaptive equipment, home safety
  3. Speech Therapy:
    - Assist with soft speech
    - Assess swallowing safety
  4. Hearing, vision, and dental care
  5. Psychological Support
  6. Surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What does PD pharmacotherapy primarily focus on?

A

Increasing dopamine levels (directly or indirectly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the 6 pharmacological classes of medications for PD management?

A
  1. Levodopa
  2. Dopamine Agonists
  3. MAO-B Inhibitors (MAOIs)
  4. Amantadine
  5. COMT Inhibitors
  6. Anticholinergics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Which PD med is the effective cornerstone of therapy?

A

Levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Levodopa is always used in combination with?

A

A peripheral decarboxylase inhibitor (carbidopa or benserazide)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Why is levodopa given in combination with a peripheral decarboxylase inhibitor? (2)

A
  1. Prevents conversion of levodopa to dopamine outside of the brain
    - Enhances efficacy
    - Reduces adverse effects
  2. Both carbidopa and benserazide cannot cross BBB
    - Levodopa → crosses BBB → converted to dopamine via decarboxylase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Initially, levodopa treatment is universally effective for: (2 - symtpoms)

A
  1. Bradykinesia
    - Usually start seeing response within days
  2. Rigidity
    - Maximal improvement in ~2 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Levodopa has variable effect on which PD symptom?

A

Tremor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Which symptoms of PD is levodopa less likely to help with? (2)

A
  1. Poor balance
  2. Non-motor symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What 3 things decrease bioavailability of levodopa?

A
  1. Protein
  2. Iron
  3. Antacids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are the adverse effects of levodopa? (5)

A
  1. Nausea, stomach upset
  2. Dizziness
  3. Fatigue
  4. Vivid dreams
  5. Confusion/hallucinations –> usually not until later stages
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

After ~5 years of treatment, complications of levodopa therapy develop. What are they? (4)

A
  1. Wearing off - meds not lasting as long as they used to
  2. On-off phenomena
  3. Freezing - inability to move
  4. Dyskinesias - abnormal, uncontrollable, involuntary movements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What is on-off phenomena?

A

Fine one minute, drug effect has totally worn off the next

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

New formulations of levodopa have been developed to address some of the limitations with oral administration. What are they?

A
  1. Duodopa - levo/carbidopa intestinal gel
  2. Vyalev - foslevodopa/foscarbidopa SQ infusion
  3. Levodopa inhaled capsules (not in Canada, don’t worry about this one)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

How is duodopa gel infusion administered?

A

Via enteral PEG-J tube
- Connected to a pump, which delivers low and constant doses of Duodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What is the benefit of Duodopa gel infusion?

A

Reduces off-time by ~2 hours/day without increasing dyskinesias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

How is Vyalev SQ infusion administered?

A

Administered via continuous subcutaneous infusion
- Connected to a pump, which delivers low and constant doses of Vyalev
- Does NOT require surgery to initiate (i.e. insertion of PEJ tube)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

The most common adverse reactions of Vyalev SQ infusion are? (3)

A
  1. Injection-site reactions
  2. Dyskinesias
  3. Psychosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What is the MOA of dopamine agonists?

A

Mimic the effect of dopamine by stimulating post-synaptic dopamine receptors

40
Q

What are the 2 subclasses of dopamine agonists?

A
  1. Ergot derivatives
  2. Non-ergot derivatives
41
Q

What are the 2 ergot derivative dopamine agonist drugs? What is there to note with this class?

A
  1. Bromocriptine
  2. Cabergoline
    - Basically never used due to pulmonary and cardiac valve toxicities
42
Q

What are the 3 non-ergot derivative dopamine agonist drugs? (3)

A
  1. Pramipexole (Mirapex)
  2. Ropinirole (Requip)
  3. Rotigotine (Neupro) - transdermal patch
43
Q

Dopamine agonists are not preferred agents for _____ ______ due to poor tolerability

A

older adults
- may be used for add-on therapy once motor complications develop if refractory/intolerant to other options

44
Q

When are dopamine agonists typically used for PD? (1)
Why is it done that way? (4)

A
  1. May be used as initial therapy in young PD patients (< 60y)
    - “Save” levodopa for later
    - Less effective for motor symptoms than levodopa
    - More side effects
    - Less risk of motor complications seen with levodopa (on-off, freezing, dyskinesias)
45
Q

Dopamine agonists may also be used for ________ ___ syndrome

A

restless leg

46
Q

What are the adverse effects of dopamine agonist drugs? (7)

A
  1. Nausea and GI upset
  2. Orthostatic hypotension
  3. Hallucinations
  4. Confusion
  5. Drowsiness, sudden sleep attacks
  6. Leg swelling
  7. Impulse control disorders (ICDs) – up to 15% of patients!
47
Q

What impulse control disorders (ICDs) might we see in patients taking dopamine agonists? (4)

A
  1. Hypersexual behavior
  2. Pathological gambling
    - Important to educate families on this
  3. Compulsive shopping
  4. Dopamine dysregulation syndrome
48
Q

True or False? Dopamine agonists can be abruptly stopped

A

False - need to be tapered off SLOWLY if discontinuing - risk of neuroleptic malignant syndrome

49
Q

Aside from the ergots, there is another dopamine agonist medication. What is it called?

A

Apomorphine

50
Q

When is apomorphine used?

A

A very potent dopamine agonist used for rescue therapy (freezing)

51
Q

What are the two forms of apomorphine?

A

Injectable (Movapo) and sublingual (Kynmobi)

52
Q

Talk about Movapo (injectable apomorphine)
- How injected (2)?
- ADEs?

A
  1. Administered via SC injection in advanced Parkinson’s
  2. May not be possible to administer without the help of others
  3. High incidence of nausea and vomiting – concurrent antiemetic recommended
53
Q

What does the enzyme MAO-B do?

A

Breaks down dopamine and other amines preferentially

54
Q

What is the MOA of MAO-B inhibitors?

A

Increase dopamine by preventing the breakdown of it via MAO-B

55
Q

What are the 2 selective MAO-B inhibitors?

A
  1. Rasagiline
  2. Selegiline
56
Q

What are 2 non-selective MAO inhibitors?

A
  1. Phenylzine
  2. Tranylcypramine
57
Q

What difference do non-selective and selective MAO-B inhibitors have in terms of diet?

A

Non-selective MAO-B inhibitors require STRICT dietary tyramine restriction because irreversible, non-selective inhibition of MAO means the body is unable to break down dietary tyramine -> hypertensive crisis, cardiac arrhythmias

58
Q

MAO-B inhibitors lose selectivity at _-_x the recommended therapeutic dose

A

2-5

59
Q

When might MAO-B inhibitors be used in PD? (3)

A
  1. Can be used for PD monotherapy for mild symptoms
  2. Less effective than levodopa
    - Fewer adverse effects and less frequent dosing
  3. May be used later in the disease course to manage motor complications with levodopa therapy (rasagiline)
    - Wearing off, freezing
60
Q

Although generally well tolerated, what are some potential ADEs of MAO-B inhibitors? (3)

A
  1. Nausea
  2. Headaches
  3. Insomnia
61
Q

MAO-B inhibitors and serotonin syndrome. How do we feel about this interaction?

A
  1. Combination of MAO-B inhibitor and serotonergic medications (SSRIs, SNRIs) unlikely to cause serotonin syndrome at recommended doses
    - May still warrant a conversation with patient and prescriber
  2. Lowest effective dose should be used
62
Q

What medication should be avoided in patients taking MAO-B inhibitors?

A

Dextromethorphan

63
Q

What is the MOA of COMT inhibitors?

A

By inhibiting the enzyme COMT, they prevent peripheral degradation of levodopa, allowing higher concs. to cross the BBB

64
Q

Name the COMT inhibitor drug

A

Entacapone (Comtan)

65
Q

How MUST entacapone be taken?

A

MUST be given with levodopa (has no effect on its own)

66
Q

What are the ADEs of COMT inhibitors? (3)

A
  1. Nausea
  2. Diarrhea
  3. May turn urine and sweat an orangey-brown color
67
Q

When starting entacapone, how does levodopa dosing need to be adjusted accordingly?

A

Decrease levodopa dosing by ~30% when starting entacapone to minimize dyskinesias

68
Q

What formal antiviral drug is now used in PD treatment?

A

Amantadine

69
Q

What role does amantadine have in PD treatment?

A

Role in PD treatment generally limited to treating bothersome dyskinesias later in the disease course

70
Q

What are the ADEs of amantadine? (4)

A
  1. Nausea
  2. Confusion
  3. Hallucinations
  4. Peripheral edema
71
Q

Name 3 anticholinergic agents that can be used in PD treatment

A
  1. Benztropine
  2. Trihexyphenidyl
  3. Procyclidine
72
Q

What is the MOA of anticholinergics (in PD specifically I guess) (2)

A
  • ↓ the amount of acetylcholine in the brain, which restores the dopamine/acetylcholine balance in the striatum
  • Effective mainly for tremor - not effective for other motor symptoms
73
Q

What is the ADE of anticholinergics?

A

It being anticholinergic lol

74
Q

Levodopa is starting to fail. What are some things we can do? (5)

A
  1. Take on an empty stomach as much as possible
  2. Increase dosing frequency for wearing-off
  3. Smaller, more frequent doses for dyskinesias
  4. Add a dose of levocarb CR @ HS
  5. Add another agent
75
Q

Levovdopa is starting to fail and we decide to add another agent. What would we add for bothersome dyskinesias?
What would we add for levodopa wearing off?

A
  1. For bothersome dyskinesias: Amantadine (may also need to consider decreasing/stopping concurrent dopamine agonist or MAO-B inhibitor)
  2. For wearing off:
    - COMT inhibitor (↓levocarb dose when adding), MAO-B inhibitor -> both ↓ off-time ~1-1.5 h/d
    - Dopamine agonist – ↓ off-time by ~2h per day
76
Q

What is the surgical treatment of PD?

A

Deep Brain Stimulation
- Electrodes are placed in movement centres in brain – function almost like “electronic levodopa” 24/7
- For advanced PD in patients with extreme motor fluctuations or dyskinesias

77
Q

True or False? Non-motor symptoms of PD aren’t substantial enough to worry about treating

A

False - often under-treated and they can have a substantial impact on QoL

78
Q

How do we manage constipation in PD? (4)

A
  1. Usual recommendations for constipation apply – increase fiber, fluids, exercise
  2. Avoid constipating medications/OTC products
  3. Domperidone can be considered to ↑ GI motility
  4. Polyethylene glycol considered first-line agent for preventing and managing constipation
    - If insufficient, may require ongoing stimulant laxative use to keep on top of PD-constipation
    – Titrate to effect
79
Q

Generally, depression in PD can be managed similarly to depression in pts without PD. What is NOT a drug of choice?

A

Bupropion not drug of choice due to additive dopaminergic effect -> may ↑ restlessness, insomnia, and dyskinesias

80
Q

Which antidepressants are safe and effective in depression treatment in PD pts? (4)

A
  1. Citalopram
  2. Sertraline
  3. Venlafaxine
  4. Duloxetine
81
Q

It is important to frequently re-evaluate the necessity of antidepressant use in patients with PD and deprescribe if possible. Why? (2)

A
  1. ↑ fall risk
  2. Contribute to orthostatic hypotension
82
Q

What is the treatment of orthostatic hypotension in PD pts? (7)

A
  1. Ensure adequate hydration
  2. Avoid eating large meals -> eat smaller meals more frequently
  3. ↑ Salt intake
  4. Stand slowly
  5. Taper/stop antihypertensives
  6. Re-evaluate other medications that can contribute
    - Antidepressants, antipsychotics
  7. Wear compression stockings
83
Q

Non-pharmacological management of urinary incontinence is preferred. What are some options? (5)

A
  1. Regular toileting
  2. ↓ Caffeine intake
  3. ↓ Fluid intake in the evening to ↓ nocturia
  4. Assistive devices to ease access
    - Bedside commode or urinal
  5. If refractory -> consider pharmacotherapy
84
Q

How might erectile dysfunction in PD be treated? (2)

A
  1. Phosphodiesterase-5 inhibitors used first-line
    - Sildenafil, tadalafil, vardenafil
  2. Apomorphine injections may be helpful
85
Q

Which of the following is TRUE of Parkinson’s disease?
A. it results from the progressive loss of dopamine-producing neurons in the frontal lobe of the brain
B. Postural instability is typically seen later on in the disease progression
C. Dopaminergic medications are important to help slow the progression of the disease
D. Increased arm swing and step length are commonly seen when walking
E. None of the above

A

B.

86
Q

Which of the following is TRUE regarding the pharmacological treatment of Parkinson’s disease?
A. MAO-B inhibitors can be used as initial drug therapy for PD
B. Dopamine agonists can be used as a “therapeutic trial”: If the pt’s motor symptoms respond to therapy, the diagnosis of PD is likely
C. COMT inhibitors can be administered prn for freezing or “off” episodes
D. Levodopa is most helpful for the tremor associated with PD
E. None of the above

A

A.

87
Q

How can we help manage drooling in PD? (4)

A
  1. Chewing gum or sucking on soft candy can help trigger swallowing reflex
  2. Ipratropium spray to mouth
  3. Atropine eye drops can also be administered sublingually to dry up extra secretions
    - Atropine 1% gtts
    - 1 drop SL Q2h prn
  4. If refractory or side effects with atropine – Botox may be considered
88
Q

Insomnia is common in PD. How do we treat/manage? (4)

A
  1. Usual sleep hygiene measures
  2. Ensure adequate control of PD motor symptoms at night (freezing, etc.)
  3. Melatonin has some evidence of benefit
  4. Low-dose doxepin or trazodone may be tried if refractory
    - Trazodone may worsen orthostatic hypotension (dose-dependent)
89
Q

What is REM Sleep Behaviour Disorder? (3)

A
  1. Loss of normal muscle atony during REM sleep
  2. Individuals act out dreams – can get violent and result in injuries
  3. Often predates diagnosis of PD
90
Q

What may worsen REM sleep behaviour disorder?

A

HS dosing of antidepressants - avoid

91
Q

If treatment of REM sleep behaviour is necessary, what can we try? (2)

A
  1. Melatonin 3-12 mg at bedtime may be tried; less evidence of efficacy but few adverse effects
  2. Clonazepam 0.125 -0.5 mg hs
92
Q

How can we help manage restless legs syndrome in PD? (3)

A
  1. Screen for iron deficiency
  2. Optimize dopaminergic therapy – consider hs dopamine agonist
  3. Second-line therapies include gabapentin or pregabalin
93
Q

What is the treatment for excessive daytime somnolence in PD?

A

Modafinil
- Stimulant indicated for narcolepsy

94
Q

True or False? All hallucinations require treatment

A

False - apparently not - as long as insight is preserved, they are relatively infrequent and not bothersome, then pharmacotherapy is not required

95
Q

How might hallucinations be treated in PD pts? (6)

A
  1. Slowly discontinue medications that may be contributing
    - Anticholinergics, amantadine, dopamine agonists, sedative/hypnotics
  2. Avoid typical antipsychotics, olanzapine, risperidone, aripiprazole
  3. Clozapine has demonstrated efficacy but not often used due to risk for agranulocytosis
  4. Quetiapine – less consistent efficacy, but has not been shown to worsen PD symptoms
  5. *Pimavanserin – FDA-approved for PD psychosis
    - NOT available in Canada yet ?special access
  6. Cholinesterase inhibitors may improve psychosis in patients with PD dementia
    - May worsen movement symptoms

PHAR 358 (12 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions